Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin

European Journal of Surgical Oncology

Volumn 41, Issue 6, 2015, Pages 713-723

  Bujko, K ^a   Glimelius, B ^b   Valentini, V ^c   Michalski, W ^a   Spalek, M ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b UPPSALA UNIVERSITY   (Sweden)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Adjuvant chemotherapy; Oxaliplatin combination; Rectal cancer

Indexed keywords

FLUOROPYRIMIDINE; OXALIPLATIN; ANTINEOPLASTIC AGENT; CAPECITABINE; DEOXYCYTIDINE; FLUOROURACIL; PLATINUM COMPLEX;

ADJUVANT CHEMORADIOTHERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; HUMAN; META ANALYSIS; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL (TOPIC); POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; ANALOGS AND DERIVATIVES; CHEMORADIOTHERAPY; COMPARATIVE STUDY; MORTALITY; MULTIMODALITY CANCER THERAPY; PREOPERATIVE CARE; PROCEDURES; RECTAL NEOPLASMS; SURVIVAL RATE; WATCHFUL WAITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FLUOROURACIL; HUMANS; ORGANOPLATINUM COMPOUNDS; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; SURVIVAL RATE; WATCHFUL WAITING;

EID: 84929129815     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.03.233     Document Type: Review

References (47)

1. Rectal cancer, NCCN clinical practice guidelines in oncology, Version I 2015 http://www.nccn.org/professionals/physician-gls/pdf/rectal.pdf [14 November 2014, date last accessed]
2. B. Glimelius, E. Tiret, A. Cervantes, D. Arnold, and E.G.W. Group Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 24 Suppl. 6 2013 vi81 vi88
3. L.O. Poulsen, C. Qvortrup, P. Pfeiffer, M. Yilmaz, U. Falkmer, and H. Sorbye Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much? Acta Oncol 54 2015 437 446
4. A.B. Haynes, Y.N. You, and C.Y. Hu Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: analysis of surveillance, epidemiology, and end results - Medicare data, 1998-2007 Cancer 120 2014 1162 1170
5. C. Tiselius, U. Gunnarsson, K. Smedh, B. Glimelius, and L. Påhlman Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study Ann Oncol 24 2013 160 165
6. C.J. van de Velde, P.G. Boelens, and J.M. Borras EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum Eur J Cancer 50 2014 1.e1 1.e34
7. K. Bujko, R. Glynne-Jones, and M. Bujko Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials Ann Oncol 21 2010 1743 1750
8. B. Glimelius, and P. Nygren Will adjuvant chemotherapy improve outcome after preoperative chemoradiation? V. Valentini, H.-J. Schmoll, C.J.H. van de Velde, Multidisciplinary management of rectal cancer 2012 Springer Berlin Heidelberg 217 225
9. Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Cochrane handbook for systematic reviews of interventions, Version 5.1.0. http://handbook.cochrane.org [14 November 2014, date last accessed].
10. W. Viechtbauer Conducting meta-analyses in R with the metafor package J Stat Softw 36 2010 1 48
11. M.K.B. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834
12. L.D. Case, G. Kimmick, E.D. Paskett, K. Lohman, and R. Tucker Interpreting measures of treatment effect in cancer clinical trials Oncologist 7 2002 181 187
13. J.F. Bosset, G. Calais, and L. Mineur Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study Lancet Oncol 15 2014 184 190
14. J.F. Bosset, and L. Collette Adjuvant chemotherapy for rectal cancer - authors' reply Lancet Oncol 15 2014 e197 e198
15. A. Sainato, V. Cernusco Luna Nunzia, and V. Valentini No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): long term results of a randomized trial (I-CNR-RT) Radiother Oncol 113 2014 223 229
16. A.J. Breugom, W. Van Gijn, and E.W. Muller Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomised phase III trial Ann Oncol 16 2015 200 207
17. R. Glynne-Jones, N. Counsell, and P. Quirke Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control Ann Oncol 25 2014 1356 1362
18. H. Schmoll, K. Haustermans, and T. Price Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: first results of the PETACC-6 randomized phase III trial J Clin Oncol 31 2013 [abstr 3531]
19. H. Schmoll, K. Haustermans, and T. Price Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: disease free survival results at interim analysis J Clin Oncol 32 5s(Suppl.) 2014 [abstr 3501]
20. C. Rodel, T. Liersch, and H. Becker Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncol 13 2012 679 687
21. C. Rodel, T. Liersch, and R. Fietkau Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: results of the German CAO/ARO/AIO-04 randomized phase III trial J Clin Oncol 32 5s(Suppl.) 2014 [abstr 3500]
22. Y.S. Hong, B.-H. Nam, and K-p Kim Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial Lancet Oncol 15 2014 1245 1253
23. H.S. Nimeiri, Y. Feng, and P.J. Catalano Intergroup randomized phase III study of postoperative irinotecan, 5-fluorouracil, and leucovorin versus oxaliplatin, 5-fluorouracil, and leucovorin versus 5-fluorouracil and leucovorin for patients with stage II or III rectal cancer receiving either preoperative radiation and 5-fluorouracil or postoperative radiation and 5-fluorouracil: ECOG E3201 - an updated survival analysis J Clin Oncol 31 Suppl. 2013 e14711
24. QUASAR Collaborative Group Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Lancet 370 2007 2020 2029
25. R. Gray, and C. McConkey Adjuvant chemotherapy for rectal cancer? Authors' reply Lancet 371 2008 1503
26. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
27. A.J. Breugom, M. Swets, and J.F. Bosset Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data Lancet Oncol 16 2015 200 207
28. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
29. M. Kornmann, L. Staib, and T. Wiegel Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer Clin Colorectal Cancer 12 2013 54 61
30. E. Benzoni, G. Terrosu, and V. Bresadola Analysis of clinical outcomes and prognostic factors of neoadjuvant chemoradiotherapy combined with surgery: intraperitoneal versus extraperitoneal rectal cancer Eur J Cancer Care 15 2006 286 292
31. S.J. Pilipshen, M. Heilweil, S.H. Quan, S.S. Sternberg, and W.E. Enker Patterns of pelvic recurrence following definitive resections of rectal cancer Cancer 53 1984 1354 1362
32. A.K. Chan, A. Wong, and D. Jenken Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys 61 2005 665 677
33. E. Fokas, T. Liersch, and R. Fietkau Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial J Clin Oncol 32 2014 1554 1562
34. T.H. Kim, H.J. Chang, and D.Y. Kim Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection Int J Radiat Oncol Biol Phys 77 2010 1158 1165
35. M. Maas, P.J. Nelemans, and V. Valentini Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
36. I.J. Park, Y.N. You, and A. Agarwal Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 2012 1770 1776
37. H.M. Quah, J.F. Chou, and M. Gonen Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation Cancer 113 2008 57 64
38. S.H. Petersen, H. Harling, L.T. Kirkeby, P. Wille-Jorgensen, and S. Mocellin Postoperative adjuvant chemotherapy in rectal cancer operated for cure Cochrane Database Syst Rev 3 2012 CD004078
39. T. Akasu, Y. Moriya, Y. Ohashi, S. Yoshida, K. Shirao, and S. Kodaira Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial Jpn J Clin Oncol 36 2006 237 244
40. T. André, C. Boni, and L. Mounedji-Boudiaf Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351
41. J.P. Kuebler, H.S. Wieand, and M.J. O'Connell Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07 J Clin Oncol 25 2007 2198 2204
42. I. Chau, A.R. Norman, and D. Cunningham Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer Eur J Cancer 41 2005 1551 1559
43. A.B. Benson 3rd, D. Schrag, and M.R. Somerfield American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol 22 2004 3408 3419
44. M. Tiv, M. Puyraveau, and L. Mineur Long-term quality of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial Cancer Radiother 14 2010 530 534
45. M. Mercier, P. Pasquet, and M. Puyraveau Evaluation of the sphincter function and quality of life in French patients with rectal cancer who entered the EORTC 22921 study Eur J Cancer 3 2 2005 171 in EJC Supplements
46. F. Mols, T. Beijers, V. Lemmens, C.J. van den Hurk, G. Vreugdenhil, and L.V. van de Poll-Franse Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry J Clin Oncol 31 2013 2699 2707
47. J.D. Harrison, M.J. Solomon, and J.M. Young Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer Arch Surg 143 2008 389 394